Pharmosa Biopharm Statistics

Total Valuation

TPEX:6875 has a market cap or net worth of TWD 6.11 billion. The enterprise value is 4.60 billion.

Market Cap	6.11B
Enterprise Value	4.60B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6875 has 129.09 million shares outstanding. The number of shares has increased by 11.49% in one year.

Current Share Class	n/a
Shares Outstanding	129.09M
Shares Change (YoY)	+11.49%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	8.74%
Owned by Institutions (%)	3.03%
Float	76.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.44
PB Ratio	3.15
P/TBV Ratio	3.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-27.63
EV / Sales	27.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.75

Financial Position

The company has a current ratio of 14.48, with a Debt / Equity ratio of 0.06.

Current Ratio	14.48
Quick Ratio	14.03
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-0.40
Interest Coverage	-90.35

Financial Efficiency

Return on equity (ROE) is -10.84% and return on invested capital (ROIC) is -8.19%.

Return on Equity (ROE)	-10.84%
Return on Assets (ROA)	-7.81%
Return on Invested Capital (ROIC)	-8.19%
Return on Capital Employed (ROCE)	-10.67%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.10
Inventory Turnover	1.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.85% in the last 52 weeks. The beta is 0.58, so TPEX:6875's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-30.85%
50-Day Moving Average	52.70
200-Day Moving Average	58.20
Relative Strength Index (RSI)	46.70
Average Volume (20 Days)	91,946

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6875 had revenue of TWD 167.57 million and -166.65 million in losses. Loss per share was -1.32.

Revenue	167.57M
Gross Profit	126.90M
Operating Income	-218.57M
Pretax Income	-166.65M
Net Income	-166.65M
EBITDA	-205.09M
EBIT	-218.57M
Loss Per Share	-1.32

Full Income Statement

Balance Sheet

The company has 1.62 billion in cash and 117.60 million in debt, giving a net cash position of 1.50 billion or 11.63 per share.

Cash & Cash Equivalents	1.62B
Total Debt	117.60M
Net Cash	1.50B
Net Cash Per Share	11.63
Equity (Book Value)	1.94B
Book Value Per Share	15.01
Working Capital	1.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -127.16 million and capital expenditures -165.27 million, giving a free cash flow of -292.43 million.

Operating Cash Flow	-127.16M
Capital Expenditures	-165.27M
Free Cash Flow	-292.43M
FCF Per Share	-2.27

Full Cash Flow Statement

Margins

Gross margin is 75.73%, with operating and profit margins of -130.43% and -99.45%.

Gross Margin	75.73%
Operating Margin	-130.43%
Pretax Margin	-99.45%
Profit Margin	-99.45%
EBITDA Margin	-122.39%
EBIT Margin	-130.43%
FCF Margin	n/a

Dividends & Yields

TPEX:6875 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.49%
Shareholder Yield	-11.49%
Earnings Yield	-2.73%
FCF Yield	-4.79%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6875 has an Altman Z-Score of 24.28.

Altman Z-Score	24.28
Piotroski F-Score	n/a